Multi-trait polygenic risk scores improve atrial fibrillation prediction, suggesting potential for better clinical use across diverse ancestries.
Polygenic scores (PGS) can improve atrial fibrillation (AF) risk prediction, both alone and alongside clinical scores, offering potential for risk prediction and guiding targeted screening. However, their limited accuracy and cross-ancestry transferability remain major barriers to clinical translation. Here, we explored several multi-PGS approaches to generate ancestry-optimized PGS for AF, and tested these in independent samples from the All of Us Research Program. Our ancestry-specific multi-trait approach, which leverages correlated traits, in particular outperformed the current gold-standard PGS among Asian individuals (OR/SD = 1.76 [1.56-1.99]; AUROC = 0.637; AUPRC = 0.055), Admixed Americans (1.45 [1.38-1.53]; 0.595; 0.054) and Africans (1.39 [1.32-1.45]; 0.573; 0.064). Although predictive accuracy remained highest among Europeans (1.89 [1.85-1.93]; 0.646; 0.157) - in whom our PGS explained 11% of AF susceptibility - our multi-trait approach yielded relatively larger gains in non-European populations. Improved risk stratification was also observed at PGS extremes, identifying a substantial proportion of European individuals with risk comparable to rare TTN variants (e.g., 5.8% with >4-fold odds). Overall, our ancestry-tailored multi-trait PGSs advance equitable AF risk prediction and provide a foundation for future implementation.
No takes yet. Share an insight, caveat, or question.
Haydarlou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: